EXHIBIT 10.12 [***] = CONFIDENTIAL PORTIONS OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. NON-EXCLUSIVE LICENSE AGREEMENT THIS NON-EXCLUSIVE LICENSE AGREEMENT ("Agreement")...Non-Exclusive License Agreement • September 16th, 2005 • Brillian Corp • Radio & tv broadcasting & communications equipment • New York
R E C I T A L S ---------------Non-Exclusive License Agreement • July 21st, 2006 • Cytodyn Inc • Pharmaceutical preparations • Massachusetts
NON-EXCLUSIVE LICENSE AGREEMENT FOR [ TITLE ]*Non-Exclusive License Agreement • March 13th, 2024
This non-exclusive license agreement (“AGREEMENT”) is effective on [DATE] (“Effective Date”), and is by and between REGENTS OF THE UNIVERSITY OF CALIFORNIA, a California corporation, whose legal address is 1111 Franklin Street, 12th Floor, Oakland, California 94607- 5200, acting through its Office of Technology Licensing, at the University of California, Berkeley, 2150 Shattuck Avenue, Suite 408, Berkeley, CA 94704-1362 ("REGENTS") and [LICENSEE name], a [State of incorporation] corporation having a principal place of business at [LICENSEE address] ("LICENSEE"). The parties agree as follows:
NON-EXCLUSIVE LICENSE AGREEMENT BETWEEN THE CITY OF MILPITAS, CALIFORNIA AND GTE MOBILNET OF CALIFORNIA LIMITED PARTNERSHIP, D/B/A VERIZON WIRELESS, FOR THE USE OF MUNICIPAL FACILITIES TO INSTALL SMALL CELL ANTENNAS AND ASSOCIATED EQUIPMENTNon-Exclusive License Agreement • September 9th, 2020 • California
This Agreement is made and entered into by and between the City of Milpitas, California, a California municipal corporation (“Licensor” or “City”) and GTE Mobilnet of California Limited Partnership, d/b/a Verizon Wireless (“Licensee”). Licensor and Licensee may be referred to herein individually as a “Party” or collectively as the “Parties.”
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • May 5th, 2020 • Michigan
This Agreement is entered into as of , 201_ (“Effective Date”), by and between Wayne State University, a non-profit Michigan educational institution (“WSU”) and
EX-10.14 17 d447521dex1014.htm EX-10.14 SPECIFIC TERMS IN THIS EXHIBIT HAVE BEEN REDACTED BECAUSE CONFIDENTIAL TREATMENT FOR THOSE TERMS HAS BEEN REQUESTED. THE REDACTED MATERIAL HAS BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION,...Non-Exclusive License Agreement • May 5th, 2020
THIS NON-EXCLUSIVE LICENSE AGREEMENT (the “Agreement”), effective as of October 31, 2013 (the “Effective Date”), is entered into by and between BioWa, Inc., with a principal place of business at 9420 Athena Circle, La Jolla, California 92037 USA (“BioWa”), Lonza Sales AG a Swiss corporation, with a principal place of business at Munchensteinerstrasse 38, Basel, CH-4002 Switzerland (“Lonza”) (together “the Licensor”) and Allakos, Inc. with its principal place of business located at 75 Shoreway Road, Suite A San Carlos CA 94070 (“Licensee”). Lonza, BioWa, Licensor or Licensee may hereafter be referred to as a “Party” and collectively as the “Parties.”
NON-EXCLUSIVE LICENSE AGREEMENT BETWEEN THE JOHNS HOPKINS UNIVERSITY CLINICAL MICRO SENSORS DBA OSMETECH MOLECULAR DIAGNOSTICS JHU Ref: 9328Non-Exclusive License Agreement • May 25th, 2010 • GenMark Diagnostics, Inc. • Surgical & medical instruments & apparatus • Maryland
This Non-exclusive License Agreement (hereinafter referred to as the “Agreement”) is by and between The Johns Hopkins University (hereinafter referred to as “JHU”), a corporation of the State of Maryland, having a principal place of business at 3400 N. Charles Street, Baltimore, Maryland 21218-2695, and Clinical Micro Sensors (hereinafter referred to as “Company”), Doing Business As Osmetech Molecular Diagnostics, a corporation incorporated in the State of California, located at 757 South Raymond Avenue., Pasadena, CA 91105.
CONFIDENTIAL TREATMENT REQUESTED NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • January 15th, 2016 • AveXis, Inc. • Biological products, (no disgnostic substances) • New York
This Non-Exclusive License Agreement (this “Agreement”) is made and entered into as of this 29th day of May, 2015 (the “Effective Date”), by and between ASKLEPIOS BIOPHARMACEUTICAL, INC., a North Carolina corporation with an address at 45 North Chatham Parkway, Chapel Hill, NC 27517 (“AskBio”), and AVEXIS, INC., a Delaware corporation with an address at 4925 Greenville Avenue, Suite 604, Dallas, Texas 75206 (“AveXis”). AskBio and AveXis may be referred to herein individually as a “Party” and collectively as the “Parties.”
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • January 31st, 2014 • uniQure B.V. • Pharmaceutical preparations • New York
This License Agreement (the “Agreement”), effective as of September 3, 2010 (the “Effective Date”), is by and between Asklêpios Biopharmaceutical, Inc., an entity organized and existing under the laws of the State of North Carolina, with its registered office located at 45 N. Chatham Parkway, Chapel Hill, NC 27517 (the “AskBio”), and Amsterdam Molecular Therapeutics (AMI) B.V., with offices located at Meibergdreef 61, 1100 DA Amsterdam, The Netherlands (“AMT”). AMT and AskBio may be hereinafter referred to individually as “Party” and jointly as “Parties”.
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • December 31st, 2021
This Non-Exclusive License Agreement (“Agreement”) is made between the Visual Information Processing and Learning (VIPL) group of Institute of Computing Technology (ICT) Chinese Academy of Sciences (CAS) and _
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • May 23rd, 2005 • A.C.T. Holdings, Inc. • Pharmaceutical preparations • Massachusetts
This Non-Exclusive License Agreement (“Agreement”) is made and entered into this 3rd day of February, 2004 (the “Effective Date”), by and between Advanced Cell Technology, Inc., a Delaware corporation with offices located at One Innovation Drive, Worcester, Massachusetts 01605 (“ACT”), and One Degree Genetics LLC, a Delaware limited liability company with offices located at 18 Plimpton Road, Westerly, R.I. 02891 (“LICENSEE”) (ACT and LICENSEE sometimes hereinafter referred to as the “parties”).
NON-EXCLUSIVE LICENSE AGREEMENT Regents of the University of MinnesotaNon-Exclusive License Agreement • February 12th, 2024
THIS NON-EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) is made as of the Effective Date by and between Regents of the University of Minnesota, a constitutional corporation under the laws of the state of Minnesota, having a place of business at 200 Oak Street, SE, Suite 280, Minneapolis, Minnesota 55455 (the “University”), and the Licensee identified below.
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • May 5th, 2020 • Massachusetts
University of Massachusetts ("University"), a public institution of higher education of the Commonwealth of Massachusetts as represented by its medical school at the Worcester campus with an address at 222 Maple Avenue, Higgins Building, Shrewsbury, MA 01545, U.S.A., and
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • October 7th, 2019 • California
CAREFULLY READ THE FOLLOWING LICENCE AGREEMENT CAREFULLY! IT CONTAINS VERY IMPORTANT INFORMATION ABOUT YOUR RIGHTS AND OBLIGATIONS, AS WELL AS LIMITATIONS AND EXCLUSIONS THAT MAY APPLY TO YOU. BY CLICKING ON THE “AGREE” BOX, YOU ARE CONSENTING TO BE BOUND BY AND ARE BECOMING A PARTY TO THIS AGREEMENT. IF YOU DO NOT AGREE TO ALL OF THE TERMS OF THIS AGREEMENT, DO NOT CLICK THE AGREE BUTTON AND LEAVE THE WEBSITE.
NON-EXCLUSIVE LICENSE AGREEMENT between Heart Test Laboratories, Inc. and Icahn School of Medicine at Mount SinaiNon-Exclusive License Agreement • September 21st, 2023 • Heart Test Laboratories, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
This Non-Exclusive License Agreement (this “Agreement”) is by and between Icahn School of Medicine at Mount Sinai, a New York not-for-profit education corporation, with a principal place of business at One Gustave L. Levy Place, New York, NY 10029 (“Mount Sinai”) and Heart Test Laboratories, Inc. d/b/a HeartSciences a Texas corporation, with a principal place of business at 550 Reserve Street, Suite 360, Southlake, TX 76092 (referred to herein as (“Licensee”). This Agreement shall become effective upon the Closing (the “Effective Date”), which shall be deemed the Closing Date. Mount Sinai and Licensee are each referred to herein as a “Party” and collectively as the “Parties.” Terms not defined herein shall have the meaning ascribed to them in the Securities Purchase Agreement between the Parties, executed contemporaneously herewith (the “SPA”) and annexed hereto as Exhibit A.
CONFIDENTIAL TREATMENT REQUESTED CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION NON-EXCLUSIVE LICENSE AGREEMENT by and between MERCK SHARP & DOHME CORP. and P53 INC.Non-Exclusive License Agreement • April 23rd, 2015 • MultiVir Inc. • Pharmaceutical preparations • New Jersey
This Non-Exclusive License Agreement (this “Agreement”), effective as of the date of last signature hereto (the “Effective Date”), is entered into by and between MERCK SHARP & DOHME CORP., a corporation organized and existing under the laws of New Jersey, having a place of business at One Merck Drive, P.O. Box 100, Whitehouse Station, New Jersey 08889 (“Merck”) and P53 INC., a corporation organized and existing under the laws of Delaware, having a place of business at 2000 Edwards Street, Houston, TX 77007 (“P53”).
Non-exclusive License AgreementNon-Exclusive License Agreement • July 14th, 2023 • Northann Corp. • Plastics products, nec • Delaware
This License Agreement (this “Agreement”) is entered into as of this 10th day of September, 2021 (the “Effective Date”), by and between Interglobal Forest LLC , an existing under the laws of United States, having a place of business at (“Licensee”) and Benchwick Construction
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • January 10th, 2008 • Rxi Pharmaceuticals Corp • Pharmaceutical preparations • Massachusetts
This Agreement, effective as of January 10, 2007 (the “Effective Date”), is between the University of Massachusetts (“University”), a public institution of higher education of the Commonwealth of Massachusetts as represented by its Worcester campus, and, RXi Pharmaceuticals Corporation (“Company”), a Delaware corporation.
Non-Exclusive License Agreement between Enteris Biopharma, Inc. and CARA THERAPEUTICS, INC. Dated as of August 20, 2019Non-Exclusive License Agreement • November 14th, 2019 • SWK Holdings Corp • Miscellaneous business credit institution • New York
This NON-EXCLUSIVE License AGREEMENT (“Agreement”) is made August 20, 2019 (the “Effective Date”) by and between CARA THERAPEUTICS, INC., incorporated and registered in the State of Delaware and having offices at 4 Stamford Plaza, 107 Elm Street, 9th Floor, Stamford, CT 06902, USA (hereinafter referred to as “Cara”), and Enteris Biopharma, Inc., incorporated and registered in the State of Delaware and having offices at 83 Fulton St., Boonton, NJ 07005, USA (hereinafter referred to as “Enteris”). Each of Enteris and Cara is sometimes referred to individually herein as a “Party” and collectively as the “Parties.”
CONFIDENTIAL Non-Exclusive License AgreementNon-Exclusive License Agreement • February 14th, 2007 • Rosetta Genomics Ltd. • Pharmaceutical preparations
This agreement (the “Agreement”) is by and between Max-Planck-Innovation GmbH, a German corporation having a principal place of business at Marstallstr. 8, 80539 Muenchen, Germany (“MI”), and Rosetta Genomics Ltd., an Israeli corporation having a principal place of business at 10 Plaut Street, Science Park, Rehovot 76706, Israel (“COMPANY”). This Agreement will become effective on December 22, 2006 (the “Effective Date”).
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • August 17th, 2015 • Syncardia Systems Inc • Surgical & medical instruments & apparatus • Minnesota
This Non-Exclusive License Agreement (“Agreement”) is effective this 27th day of July, 2013 (“Effective Date”), between Medtronic Inc., having an address at 8200 Coral Sea Street N.E., Moundsview, MN 55112 (“Medtronic”), and SynCardia Systems, Inc., having an address at 1992 Silverlake Road, Tucson, AZ 85713 (“SynCardia”). Each of Medtronic and SynCardia is referred to herein individually as a “Party” and together as the “Parties.”
EAST SILVER NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • February 18th, 2021
EAST SILVER, a project duly organized and validly existing under the laws of the Czech Republic, having the address of Stepanska 14, 110 00 Praha 1, Czech Republic (hereinafter “LICENSEE”).
EX-10.45 9 dex1045.htm NON-EXCLUSIVE LICENSE AGREEMENT BETWEEN SEATTLE GENETICS, INC. AND ICOS CORP. NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • May 5th, 2020 • Washington
This Non-exclusive License Agreement (the “Agreement”), effective as of October 16th, 2000 (The “Effective Date”), is entered into by and between ICOS Corporation, a Delaware corporation having offices at 22021 20th Avenue SE, Bothell, WA 98021, U.S.A., (“ICOS”), and Seattle Genetics, Inc., a Delaware corporation having offices at 22215 26th Avenue S.E., Suite 300, Bothell, WA 98021 (“LICENSEE”). All references to LICENSEE in this Agreement shall include its Affiliates (as such term is defined below).
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • July 11th, 2005 • Coley Pharmaceutical Group, Inc. • Pharmaceutical preparations • Massachusetts
This NON-EXCLUSIVE LICENSE AGREEMENT (this “Agreement”), effective as of December 22, 2003 (the “Effective Date”), is between Coley Pharmaceutical Group, Inc., a Delaware corporation located at 93 Worcester Street, Suite 101, Wellesley, Massachusetts 02481 (“Coley”), and Chiron Corporation., a Delaware corporation having a principal place of business at 4560 Horton Street, Emeryville, California 94608 (“Licensee”) (each, a “Party” and collectively, the “Parties”).
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • May 5th, 2020 • Georgia
WHEREAS, EMORY is the assignee of all right, title, and interest in inventions developed by the employees of EMORY and is responsible for the protection and commercial development of such inventions; and
NON-EXCLUSIVE LICENSE AGREEMENT (Buyer Out-License Agreement)Non-Exclusive License Agreement • September 17th, 2014 • Medifocus Inc. • Surgical & medical instruments & apparatus • Massachusetts
This Non-Exclusive License Agreement (the “Agreement”) is made as of July 24, 2012 (the “Effective Date”) by and between MEDIFOCUS, INC., a Canadian corporation (“Licensor”) and BOSTON SCIENTIFIC CORPORATION, a Delaware corporation (“Licensee”).
NON-EXCLUSIVE LICENSE AGREEMENT WITH SUBLICENSING TERMSNon-Exclusive License Agreement • January 10th, 2014 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances)
This Agreement is made effective the 19th day of January 2006 (hereinafter “Effective Date”) by and between The UAB Research Foundation (hereinafter “UABRF”), a nonstock, nonprofit Alabama corporation having an office at 701 20th Street South, Birmingham, AL 35294 USA and AGTC (hereinafter “Licensee”), a corporation organized and existing under the laws of Delaware and having a principal office at 12085 Research Drive, Alachua, Florida 32615.
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • September 11th, 2020 • Oncorus, Inc. • Pharmaceutical preparations • Missouri
This Non-Exclusive License Agreement for Antibodies (“Agreement”) is made and entered into as of July 7, 2016 (the “Effective Date”) by and between: The Washington University, a corporation established by special act of the Missouri General Assembly approved February 22, 1853 and acts amendatory thereto, through its Office of Technology Management having its principal offices at 4240 Duncan Avenue, Suite 110, St. Louis, MO 63110 (hereinafter referred to as “WU”); and Oncorus, Inc., a corporation organized and existing under the laws of the State of Delaware, having its principal offices at 450 Kendall Street, Cambridge, MA 02142 (hereinafter referred to as “Licensee”). WU and Licensee are each a “Party” or collectively the “Parties” of this Agreement.
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • June 20th, 2012 • Stemline Therapeutics Inc • Pharmaceutical preparations • Pennsylvania
This Agreement is made and entered into as of the 30th day of March, 2012 (“Effective Date”), by and between the University of Pittsburgh — Of the Commonwealth System of Higher Education, a non-profit corporation, organized and existing under the laws of the Commonwealth of Pennsylvania, having an office at 200 Gardner Steel Conference Center, Thackeray and O’Hara Street, Pittsburgh, Pennsylvania 15260 (“University”), and Stemline Therapeutics, Inc., having its principal office at ***, New York, New York 10128 (“Licensee”).
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • January 10th, 2008 • Rxi Pharmaceuticals Corp • Pharmaceutical preparations • Massachusetts
This Agreement, effective as of April 15, 2003 (the “Effective Date”), is between the University of Massachusetts Medical School (“Medical School”), a public institution of higher education of the Commonwealth of Massachusetts having an address of 55 Lake Avenue North, Worcester, MA 01655 and CytRx Corporation (“Company”), a Delaware corporation having an address of 11726 San Vicente Blvd., Suite 650, Los Angeles, CA 90049.
EX-10.33 5 d265091dex1033.htm NON-EXCLUSIVE LICENSE AGREEMENT Execution Version CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[**]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE...Non-Exclusive License Agreement • May 5th, 2020 • Delaware
This Non-Exclusive License Agreement (this “Agreement”), made and entered into as of October 21, 2011 (the “Effective Date”), is by and between, on the one hand, F. Hoffmann-La Roche Ltd, a corporation organized under the laws of Switzerland, with an office and place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland (“Roche Basel”) and Hoffmann-La Roche Inc., a corporation organized under the laws of the State of New Jersey, with an office and place of business at 340 Kingsland Street, Nutley, New Jersey 07110, U.S.A. (“Roche Nutley”; Roche Basel and Roche Nutley together referred to as “Roche”), and, on the other hand, Arrowhead Research Corporation, a corporation organized under the laws of the State of Delaware, having a primary business address at 225 South Lake Avenue, 3rd Floor, Pasadena, California 91101(“Arrowhead”) (collectively, the “Parties”, or each separately, a “Party” ).
NON-EXCLUSIVE LICENSE AGREEMENT PREAMBLENon-Exclusive License Agreement • December 16th, 2014 • World Surveillance Group Inc. • Telephone communications (no radiotelephone) • New York
This Non-Exclusive License Agreement (this “Agreement”) is made and entered into effective as of December 10, 2014 (the “Effective Date”) by and among World Surveillance Group Inc. (hereinafter referred to as “World”), Global Telesat Corp. (hereinafter referred to as “GTC”), a wholly-owned subsidiary of World, Great West Resources, Inc. (hereinafter referred to as “Parent”), and Orbital Satcom Corp., a wholly owned subsidiary of Parent (hereinafter referred to as “Licensee” and, together with GTC, World and Parent, the “Parties”).
CONFIDENTIAL NON-EXCLUSIVE LICENSE AGREEMENT [“Cabilly Patents”]Non-Exclusive License Agreement • September 25th, 2014 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances) • California
This Non-Exclusive License Agreement (“Agreement”) is effective as of July 10, 2013 (“Effective Date”) by and between Genentech, Inc., a corporation having its principal place of business at 1 DNA Way, South San Francisco, California 94080 (hereinafter “Genentech”) and Coherus Biosciences, Inc., a corporation having its principal place of business at 201 Redwood Shores Parkway, Suite 200, Redwood City, CA 94065 (hereinafter “Coherus”).
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • March 31st, 2015 • Anterios Inc • Pharmaceutical preparations • Massachusetts
This Agreement, effective as of August 13 , 2007 (the “Effective Date”), is between the University of Massachusetts (“University”), a public institution of higher education of the Commonwealth of Massachusetts as represented by its Dartmouth campus, and, Anterios, Inc. (f/k/a Encapsion, Inc.) (“Company”), a Delaware corporation with headquarters at 41 West 57th Street (6th floor), New York, New York 10019.
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • May 5th, 2020 • Massachusetts
University of Massachusetts ("University"), a public institution of higher education of the Commonwealth of Massachusetts as represented by its medical school at the Worcester campus with an address at 222 Maple Avenue, Higgins Building, Shrewsbury, MA 01545, U.S.A., and
